ASX
Alterity Therapeutics Limited
ATH:ASX•Healthcare
Sensitive ASX Announcement
FDA Orphan Drug Designation for PBT2 for Huntington Disease
Published: 05/09/14, 01:33pm (AEST)•2 pages